Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
Condition:   Alcoholic HepatitisIntervention:   Drug: IDN-6556Sponsors:   Conatus Pharmaceuticals Inc.;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)Recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2013 Category: Research Source Type: clinical trials

Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
Condition:   Alcoholic HepatitisIntervention:   Drug: IDN-6556Sponsors:   Conatus Pharmaceuticals Inc.;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)Recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2013 Category: Research Source Type: clinical trials

Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
Condition:   Alcoholic HepatitisIntervention:   Drug: IDN-6556Sponsors:   Conatus Pharmaceuticals Inc.;   Conatus Pharmaceuticals Inc.;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)Recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2013 Category: Research Source Type: clinical trials